X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-05-01 | PRCT | Procept Biorobotics Corp | Krummel Thomas M | Dir | S - Sale | $60.00 | -20,000 | 45,631 | -30% | -$1,200,000 | ||||||
D | 2024-05-03 | PRCT | Procept Biorobotics Corp | Nouri Alaleh | EVP, CLO, CORP. SEC. | S - Sale+OE | $62.97 | -30,432 | 62,472 | -33% | -$1,916,428 | |||||
2024-05-01 | SYM | Symbotic Inc. | Dunn Michael David | See Remarks | S - Sale | $40.00 | -2,000 | 72,032 | -3% | -$80,000 | ||||||
2024-05-01 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $93.97 | -1,866 | 67,542 | -3% | -$175,344 | ||||||
M | 2024-05-01 | TNGX | Tango Therapeutics, Inc. | Mva Investors, LLC | See remarks | S - Sale | $7.53 | -210,000 | 488,524 | -30% | -$1,580,850 | |||||
D | 2024-05-03 | VKTX | Viking Therapeutics, Inc. | Zante Greg | CFO | S - Sale+OE | $74.69 | -66,756 | 174,854 | -28% | -$4,986,008 | |||||
D | 2024-05-01 | UBI | Universal Biosensors Inc | Coleman Craig E. | Dir, 10% | P - Purchase | $0.15 | +29,506,606 | 87,058,827 | +51% | +$4,425,991 | |||||
DM | 2024-05-01 | GCT | Gigacloud Technology Inc | Wu Lei | CEO, 10% | S - Sale+OE | $32.70 | -88,000 | 621,816 | -12% | -$2,877,966 | |||||
2024-05-02 | CVNA | Carvana Co. | Keeton Ryan S. | Chief Brand Officer | S - Sale | $115.55 | -8,250 | 187,256 | -4% | -$953,246 | ||||||
2024-05-02 | CVNA | Carvana Co. | Garcia Ernest C. III | CEO, 10% | S - Sale | $116.24 | -18,100 | 2,696,449 | -1% | -$2,104,018 | ||||||
M | 2024-05-01 | CVNA | Carvana Co. | Palmer Stephen R | VP of Accounting | S - Sale | $88.38 | -5,480 | 56,392 | -9% | -$484,320 | |||||
DM | 2024-05-01 | CVNA | Carvana Co. | Jenkins Mark W. | CFO | S - Sale+OE | $93.27 | -73,000 | 198,523 | -27% | -$6,808,648 | |||||
2024-05-02 | CVNA | Carvana Co. | Taira Thomas | Pres, Special Projects | S - Sale | $114.63 | -11,300 | 186,926 | -6% | -$1,295,368 | ||||||
A | 2022-03-04 | CVNA | Carvana Co. | Maroone Michael E | Dir | P - Purchase | $104.77 | +25,000 | 70,224 | +55% | +$2,619,250 | |||||
M | 2024-05-01 | LYFT | Lyft, Inc. | Sverchek Kristin | Pres | S - Sale | $16.22 | -10,000 | 1,046,534 | -1% | -$162,249 | |||||
2024-05-01 | MU | Micron Technology Inc | Deboer Scott J | EVP, Technology, Products | S - Sale | $110.31 | -40,000 | 158,617 | -20% | -$4,412,400 | ||||||
2024-05-01 | THC | Tenet Healthcare Corp | Arnst Thomas W | EVP, Chief Admin. Officer, GC | S - Sale | $116.10 | -8,148 | 0 | -100% | -$945,994 | ||||||
AM | 2024-05-02 | COLM | Columbia Sportswear Co | Simmons Sabrina | Dir | S - Sale | $81.93 | -1,041 | 5,965 | -15% | -$85,293 | |||||
DM | 2024-05-02 | CVNA | Carvana Co. | Breaux Paul W. | See Remarks | S - Sale+OE | $120.15 | -56,400 | 130,358 | -30% | -$6,776,569 | |||||
2024-05-02 | CVNA | Carvana Co. | Huston Benjamin E. | COO | S - Sale | $115.07 | -18,000 | 213,548 | -8% | -$2,071,256 | ||||||
2024-05-02 | CVNA | Carvana Co. | Gill Daniel J. | Chief Product Officer | S - Sale | $117.34 | -29,700 | 409,427 | -7% | -$3,485,054 | ||||||
M | 2024-05-02 | LBRT | Liberty Energy Inc. | Wright Christopher A | COB, CEO | S - Sale | $21.52 | -40,000 | 2,818,814 | -1% | -$860,600 | |||||
M | 2024-05-01 | TMUS | T-Mobile Us, Inc. | Deutsche Telekom AG | Dir, 10% | S - Sale | $165.11 | -569,010 | 677,158,691 | 0% | -$93,948,129 | |||||
2024-05-03 | AMGN | Amgen Inc | Grygiel Nancy A. | SVP, CCO | S - Sale | $313.09 | -2,117 | 9,983 | -17% | -$662,802 | ||||||
D | 2024-05-01 | DUOL | Duolingo, Inc. | Hacker Severin | Chief Tech Officer, Co-Founder, 10% | S - Sale+OE | $223.47 | -10,000 | 72 | -99% | -$2,234,653 | |||||
D | 2024-05-01 | DUOL | Duolingo, Inc. | Skaruppa Matthew | CFO | S - Sale+OE | $223.46 | -8,000 | 64,523 | -11% | -$1,787,708 | |||||
D | 2024-05-01 | DUOL | Duolingo, Inc. | Von Ahn Luis | Pres, CEO, Co-Founder, 10% | S - Sale+OE | $223.51 | -12,000 | 0 | -100% | -$2,682,139 | |||||
D | 2024-05-03 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale+OE | $40.03 | -10,000 | 101,959 | -9% | -$400,260 | |||||
M | 2024-05-02 | EXPO | Exponent Inc | James Bradley A | Group VP | S - Sale | $93.77 | -5,558 | 5,558 | -50% | -$521,167 | |||||
DM | 2024-05-01 | ATEX | Anterix Inc. | Gray Timothy | CFO | S - Sale+OE | $32.09 | -50,000 | 90,475 | -36% | -$1,604,453 | |||||
2024-05-03 | VRNA | Verona Pharma Plc | Rickard Kathleen A. | Chief Medical Officer | S - Sale | $1.96 | -36,248 | 2,621,552 | -1% | -$71,032 | ||||||
D | 2024-05-02 | HOOD | Robinhood Markets, Inc. | Tenev Vladimir | CEO | S - Sale+OE | $17.04 | -25,049 | 39,491 | -39% | -$426,875 | |||||
2024-05-01 | HOOD | Robinhood Markets, Inc. | Warnick Jason | CFO | S - Sale | $16.72 | -5,000 | 997,407 | 0% | -$83,602 | ||||||
M | 2024-05-01 | HLVX | Hillevax, Inc. | Kohli Aditya | Dir | S - Sale | $14.03 | -6,898 | 782,878 | -1% | -$96,770 | |||||
D | 2024-05-01 | ANET | Arista Networks, Inc. | Taxay Marc | SVP, GC | S - Sale+OE | $254.54 | -1,044 | 0 | -100% | -$265,740 | |||||
D | 2024-05-01 | ANET | Arista Networks, Inc. | McCool John F | Chief Platform Officer | S - Sale+OE | $254.54 | -416 | 0 | -100% | -$105,889 | |||||
2024-05-01 | ANET | Arista Networks, Inc. | Giancarlo Charles H | Dir | S - Sale | $255.83 | -2,000 | 110,638 | -2% | -$511,669 | ||||||
2024-05-01 | ROKU | Roku, Inc | Banks Matthew C. | VP, Corp Controller, CAO | S - Sale | $57.28 | -206 | 5,162 | -4% | -$11,800 | ||||||
2024-05-01 | MRNA | Moderna, Inc. | Afeyan Noubar | Dir | S - Sale | $110.92 | -15,000 | 11,692,969 | 0% | -$1,663,855 | ||||||
2024-05-01 | GDYN | Grid Dynamics Holdings, Inc. | Doradla Anil | CFO | S - Sale | $10.00 | -3,000 | 385,979 | -1% | -$30,000 | ||||||
2024-05-02 | AMKR | Amkor Technology, Inc. | Rogers Mark N | EVP, GC | S - Sale | $31.30 | -5,000 | 25,280 | -17% | -$156,500 | ||||||
2024-05-01 | IOT | Samsara Inc. | Phillips Dominic | See remarks | S - Sale | $34.94 | -21,053 | 2,220,121 | -1% | -$735,639 | ||||||
M | 2024-05-01 | DAWN | Day One Biopharmaceuticals, Inc. | Bender Jeremy | CEO | S - Sale | $17.87 | -79,211 | 1,686,326 | -4% | -$1,415,707 | |||||
M | 2024-05-01 | DAWN | Day One Biopharmaceuticals, Inc. | York Charles N II | COO, CFO, Secretary | S - Sale | $17.88 | -60,461 | 217,293 | -22% | -$1,081,191 | |||||
2024-05-01 | WEX | Wex Inc. | Trickett Sara | SVP, Acting GC | S - Sale | $210.43 | -734 | 0 | -100% | -$154,456 | ||||||
M | 2024-05-01 | WLDN | Willdan Group, Inc. | Forager Fund, L.P. | 10% | S - Sale | $30.13 | -157,366 | 1,654,706 | -9% | -$4,741,227 | |||||
2024-05-03 | BANF | Bancfirst Corp /ok/ | Hannah Dennis Jay | EVP | S - Sale | $92.38 | -204 | 27,604 | -1% | -$18,846 | ||||||
D | 2024-05-01 | HIMS | Hims & Hers Health, Inc. | Dudum Andrew | CEO, 10% | S - Sale+OE | $12.60 | -333,332 | 11,241,475 | -3% | -$4,200,307 | |||||
DM | 2024-05-01 | HIMS | Hims & Hers Health, Inc. | Baird Melissa | COO | S - Sale+OE | $12.11 | -35,250 | 538,932 | -6% | -$426,871 | |||||
D | 2024-05-02 | DTIL | Precision Biosciences Inc | Scimeca Dario | GC, Secretary | S - Sale+OE | $10.32 | -272 | 5,680 | -5% | -$2,807 | |||||
D | 2024-05-02 | DTIL | Precision Biosciences Inc | Smith J. Jefferson | Chief Research Officer | S - Sale+OE | $10.32 | -154 | 75,544 | 0% | -$1,589 | |||||
2024-05-03 | ETST | Earth Science Tech, Inc. | Saumat Giorgio R. | CEO, 10% | P - Purchase | $0.10 | +100,000 | 121,218,579 | 0% | +$10,350 | ||||||
D | 2024-05-03 | DXLG | Destination Xl Group, Inc. | Fund 1 Investments, LLC | 10% | S - Sale+OE | $3.15 | -225,000 | 5,729,290 | -4% | -$708,795 | |||||
D | 2024-05-02 | EWTX | Edgewise Therapeutics, Inc. | Moore John R | GC | S - Sale+OE | $18.91 | -1,956 | 3,252 | -38% | -$36,988 | |||||
D | 2024-05-02 | DTIL | Precision Biosciences Inc | List Alan | Chief Medical Officer | S - Sale+OE | $10.32 | -290 | 4,488 | -6% | -$2,993 | |||||
D | 2024-05-02 | EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | CFO | S - Sale+OE | $18.91 | -2,157 | 35,230 | -6% | -$40,789 | |||||
D | 2024-05-02 | DTIL | Precision Biosciences Inc | Amoroso Michael | Pres, CEO | S - Sale+OE | $10.32 | -1,526 | 13,772 | -10% | -$15,748 | |||||
D | 2024-05-02 | EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Officer | S - Sale+OE | $18.91 | -1,718 | 13,422 | -11% | -$32,487 | |||||
D | 2024-05-02 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | S - Sale+OE | $18.91 | -1,576 | 7,238 | -18% | -$29,802 | |||||
D | 2024-05-01 | ZM | Zoom Video Communications, Inc. | Steckelberg Kelly | CFO | S - Sale+OE | $61.42 | -5,007 | 102,176 | -5% | -$307,519 | |||||
D | 2024-05-02 | EWTX | Edgewise Therapeutics, Inc. | Donovan Joanne M. | CMO | S - Sale+OE | $18.91 | -3,682 | 19,897 | -16% | -$69,627 | |||||
D | 2024-05-02 | EWTX | Edgewise Therapeutics, Inc. | Koch Kevin | Pres, CEO | S - Sale+OE | $18.91 | -3,152 | 353,262 | -1% | -$59,604 | |||||
DM | 2024-05-01 | RXRX | Recursion Pharmaceuticals, Inc. | Gibson Christopher | CEO | S - Sale+OE | $8.10 | -100,000 | 834,820 | -11% | -$810,000 | |||||
2024-05-01 | GDDY | Godaddy Inc. | Chen Roger | COO | S - Sale | $122.60 | -4,000 | 200,632 | -2% | -$490,400 | ||||||
M | 2024-05-01 | IZEA | Izea Worldwide, Inc. | Gp Investments, Ltd. | 10% | P - Purchase | $2.91 | +29,230 | 1,857,469 | +2% | +$85,005 | |||||
2024-05-01 | PLTR | Palantir Technologies Inc. | Moore Alexander D. | Dir | S - Sale | $22.02 | -20,000 | 1,595,519 | -1% | -$440,306 | ||||||
M | 2024-05-01 | HTLD | Heartland Express Inc | Gerdin Michael J | CEO, 10% | P - Purchase | $10.74 | +107,605 | 31,638,740 | 0% | +$1,155,307 | |||||
2024-05-01 | TNET | Trinet Group, Inc. | Chamberlain Paul Edward | Dir | S - Sale | $101.02 | -375 | 36,341 | -1% | -$37,883 | ||||||
M | 2024-05-02 | MRBK | Meridian Corp | Annas Christopher J. | COB, CEO | P - Purchase | $9.15 | +3,000 | 359,378 | +1% | +$27,450 | |||||
2024-05-01 | CDNS | Cadence Design Systems Inc | Nisewaner Karna | SVP, GC | S - Sale | $275.36 | -600 | 20,480 | -3% | -$165,216 | ||||||
2024-05-01 | CDNS | Cadence Design Systems Inc | Cunningham Paul | SVP | S - Sale | $275.36 | -1,000 | 67,144 | -1% | -$275,360 | ||||||
2024-05-01 | EXFY | Expensify, Inc. | McLaughlin Steven J. | 10% | P - Purchase | $1.60 | +11,972 | 11,341,889 | 0% | +$19,155 | ||||||
D | 2024-05-02 | ACAD | Acadia Pharmaceuticals Inc | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $16.94 | -3,503 | 32,053 | -10% | -$59,341 | |||||
D | 2024-05-02 | ACAD | Acadia Pharmaceuticals Inc | Teehan Brendan | EVP, COO, Head of Commercial | S - Sale+OE | $16.94 | -3,477 | 42,133 | -8% | -$58,900 | |||||
D | 2024-05-02 | ACAD | Acadia Pharmaceuticals Inc | Kihara James | PRINCIPAL ACCOUNTING OFFICER | S - Sale+OE | $16.94 | -1,326 | 14,370 | -8% | -$22,462 | |||||
D | 2024-05-02 | ACAD | Acadia Pharmaceuticals Inc | Davis Stephen | CEO | S - Sale+OE | $16.94 | -11,427 | 155,231 | -7% | -$193,573 | |||||
2024-05-02 | RKT | Rocket Companies, Inc. | Rizik Matthew | Dir | P - Purchase | $12.33 | +97 | 699,330 | 0% | +$1,196 | ||||||
2024-05-02 | AVTE | Aerovate Therapeutics, Inc. | Verwijs Marinus | CHIEF TECHNICAL OFFICER | S - Sale | $21.02 | -1,981 | 0 | -100% | -$41,631 | ||||||
D | 2024-05-01 | AVTE | Aerovate Therapeutics, Inc. | Noyes Timothy P | CEO | S - Sale+OE | $20.34 | -11,357 | 0 | -100% | -$230,946 | |||||
2024-05-01 | AFRM | Affirm Holdings, Inc. | Rabois Keith | Dir | S - Sale | $32.12 | -9,276 | 60,000 | -13% | -$297,902 | ||||||
2024-05-03 | QCOM | Qualcomm Inc/de | Thompson James H | CTO | S - Sale | $182.00 | -8,000 | 349,338 | -2% | -$1,456,000 | ||||||
M | 2024-05-01 | JNPR | Juniper Networks Inc | Rahim Rami | CEO | S - Sale | $34.81 | -16,665 | 986,764 | -2% | -$580,033 | |||||
2024-05-01 | EA | Electronic Arts Inc. | Singh Vijayanthimala | Chief People Officer | S - Sale | $126.64 | -800 | 26,283 | -3% | -$101,312 | ||||||
2024-05-01 | EA | Electronic Arts Inc. | Miele Laura | COO | S - Sale | $128.15 | -2,000 | 32,772 | -6% | -$256,303 | ||||||
D | 2024-05-01 | ACLX | Arcellx, Inc. | Heery Christopher | CHIEF MEDICAL OFFICER | S - Sale+OE | $51.33 | -18,168 | 8,938 | -67% | -$932,557 | |||||
2024-05-01 | ANIP | Ani Pharmaceuticals Inc | Gassert Chad | SVP - CORP. DEV., STRATEGY | S - Sale | $66.62 | -20,000 | 282,905 | -7% | -$1,332,400 | ||||||
2024-05-03 | NWPP | New Peoples Bankshares Inc | Cox John D | Dir | P - Purchase | $2.51 | +5,000 | 660,189 | +1% | +$12,550 | ||||||
M | 2024-05-02 | CRDO | Credo Technology Group Holding Ltd | Brennan William Joseph | Pres, CEO | S - Sale | $17.25 | -30,000 | 3,625,779 | -1% | -$517,547 | |||||
2024-05-01 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $42.00 | -38,549 | 965,359 | -4% | -$1,619,047 | ||||||
D | 2024-05-01 | NET | Cloudflare, Inc. | Kramer Douglas James | GC | S - Sale+OE | $88.12 | -3,000 | 205,238 | -1% | -$264,360 | |||||
M | 2024-05-01 | MOFG | Midwestone Financial Group, Inc. | Reeves Charles N | CEO | P - Purchase | $21.08 | +2,000 | 70,474 | +3% | +$42,168 | |||||
2024-05-02 | UVE | Universal Insurance Holdings, Inc. | Downes Sean P | Exec COB | S - Sale | $19.72 | -20,000 | 1,182,262 | -2% | -$394,434 | ||||||
M | 2024-05-01 | LEVI | Levi Strauss & Co | Friedman David A | Dir | S - Sale | $21.42 | -16,666 | 226,197 | -7% | -$357,027 | |||||
M | 2024-05-01 | RUM | Rumble Inc. | Arsov Robert | Dir | S - Sale | $6.77 | -105,012 | 15,208,902 | -1% | -$710,922 | |||||
DM | 2024-05-01 | FCX | Freeport-McMoran Inc | Higgins Stephen T. | SVP, CAO | S - Sale+OE | $50.72 | -86,667 | 140,402 | -38% | -$4,395,592 | |||||
2024-05-02 | AMTB | Amerant Bancorp Inc. | Iafigliola Carlos | SEVP COO | S - Sale | $22.62 | -10,579 | 9,961 | -52% | -$239,298 | ||||||
M | 2024-05-01 | TRS | Trimas Corp | Parker Herbert K | Dir | P - Purchase | $26.24 | +4,000 | 33,057 | +14% | +$104,960 | |||||
D | 2024-05-01 | FCX | Freeport-McMoran Inc | Mikes Ellie L. | Chief Accounting Officer | S - Sale+OE | $50.97 | -4,333 | 43,572 | -9% | -$220,858 | |||||
M | 2024-05-01 | FRTX | Fresh Tracks Therapeutics, Inc. | Exploration Capital, LLC | 10% | P - Purchase | $0.92 | +164,897 | 1,272,723 | +15% | +$151,680 | |||||
2024-05-02 | W | Wayfair Inc. | Schaferkordt Anke | Dir | S - Sale | $58.81 | -348 | 13,251 | -3% | -$20,465 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |